Cargando…
Targeting mitochondria in cancer therapy could provide a basis for the selective anti-cancer activity
To determine the target of the recently identified lead compound NSC130362 that is responsible for its selective anti-cancer efficacy and safety in normal cells, structure-activity relationship (SAR) studies were conducted. First, NSC13062 was validated as a starting compound for the described SAR s...
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433232/ https://www.ncbi.nlm.nih.gov/pubmed/30908483 http://dx.doi.org/10.1371/journal.pone.0205623 |